Cargando…
Medical cannabinoids for painful symptoms in patients with severe dementia: a randomized, double-blind cross-over placebo-controlled trial protocol
BACKGROUND: In an observational study in Geneva (Switzerland), we found that administering a standardized THC/CBD oil was feasible, safe, and beneficial in an elderly polymedicated population with severe dementia, behavioral troubles, and pain. Those findings need to be confirmed in a randomized cli...
Autores principales: | Bianchi, Federica, Pautex, Sophie, Wampfler, James, Curtin, François, Daali, Youssef, Desmeules, Jules Alexandre, Broers, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244760/ https://www.ncbi.nlm.nih.gov/pubmed/37293434 http://dx.doi.org/10.3389/fpain.2023.1108832 |
Ejemplares similares
-
Cannabinoids for behavioral symptoms in severe dementia: Safety and feasibility in a long-term pilot observational study in nineteen patients
por: Pautex, Sophie, et al.
Publicado: (2022) -
Patient-Related Barriers to the Prescription of Cannabinoid-Based Medicines in Palliative Care: A Qualitative Approach
por: Kalonji, Pauline, et al.
Publicado: (2022) -
Physiologically‐Based Pharmacokinetic Modeling for the Prediction of CYP2D6‐Mediated Gene–Drug–Drug Interactions
por: Storelli, Flavia, et al.
Publicado: (2019) -
High-dose steroids in high pain responders undergoing total knee arthroplasty: a randomised double-blind trial
por: Nielsen, Niklas I., et al.
Publicado: (2022) -
Uptake/Efflux Transport of Tramadol Enantiomers and O-Desmethyl-Tramadol: Focus on P-Glycoprotein
por: Kanaan, Mouna, et al.
Publicado: (2009)